Industry Research Reports
Home > Reports > Machinery & Equipment > Global Pharmaceutical Dry Granulator Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Dry Granulator Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Machinery & Equipment
Published Date: 2025-11-02
Pages: 170 Pages
Report ld: 5367219
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Dry Granulator Market Size(US$)
CAGR 2025-2031
6.0%
Market Size,2031
USD 159
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 112 million
Market Forecast in 2031(Value)
US$ 159 million
CAGR
6.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Dry Granulator market is projected to grow from US$ 105 million in 2024 to US$ 159 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharmaceutical Dry Granulators, also known as roll press granulators, are machines used in the dry granulation process to produce uniform, high-quality granules for the pharmaceutical industry. These machines apply pressure to the powder, compacting it into dense sheets, which are then broken down into granules. The process is particularly advantageous for heat-sensitive or moisture-sensitive materials, as it does not require the use of liquids or heat, making it suitable for certain types of pharmaceutical formulations.
The Pharmaceutical Dry Granulators market is a segment within the pharmaceutical manufacturing equipment industry focused on the production and sale of roller compactors, also known as roll press granulators. These machines are used to create granules from dry powder, which is a critical step in the manufacturing of solid oral dosage forms such as tablets and capsules. The market is driven by the increasing demand for high-quality pharmaceuticals, the shift toward more efficient and cost-effective manufacturing processes, and technological advancements in the field of dry granulation. The global pharmaceutical industry is expanding rapidly due to rising health concerns, the aging population, and increased access to healthcare services. This has led to a higher demand for pharmaceuticals, including generics and over-the-counter (OTC) drugs, which in turn drives the need for efficient manufacturing equipment like roller compactors. Roller compacting offers a significant advantage over wet granulation because it eliminates the need for liquid binders and drying processes. This results in reduced production time, energy consumption, and cost, making it an attractive solution for pharmaceutical manufacturers. The growing availability of generic drugs worldwide, particularly in markets like North America, Asia-Pacific, and Europe, is increasing the demand for efficient, cost-effective granulation equipment. Roller compactors are particularly suited for manufacturing high-dose generic formulations, which require high-quality granules for consistency. Increasing regulatory scrutiny, especially from agencies like the FDA and EMA, is pushing manufacturers to adopt more efficient and precise production processes. Roller compactors help in achieving uniform granule size distribution, which is crucial for ensuring consistent tablet weight, uniformity, and drug release characteristics.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Dry Granulator market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Fitzpatrick
- Hosokawa
- Alexanderwerk
- Freund Corporation
- Beijing LongliTech
- GERTEIS
- L.B. Bohle
- Yenchen Machinery
- WelchDry
- Cadmach
- Canaan Technology
- Bepex
- Prism Pharma Machinery
- KEYUAN
- KaiChuang Machinery
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Below 30Kg/Hour
- 30-200Kg/Hour
- Above 200Kg/Hour
Segment by Application
- Mid-size & Small Pharma Companies
- Large Pharma Companies
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Dry Granulator study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Dry Granulator: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Dry Granulator Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Below 30Kg/Hour
1.2.3 30-200Kg/Hour
1.2.4 Above 200Kg/Hour
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Dry Granulator Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Mid-size & Small Pharma Companies
1.3.3 Large Pharma Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Dry Granulator Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Dry Granulator Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Dry Granulator Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Dry Granulator Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharmaceutical Dry Granulator Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharmaceutical Dry Granulator Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharmaceutical Dry Granulator Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Below 30Kg/Hour Market Size by Manufacturers
4.5.2 30-200Kg/Hour Market Size by Manufacturers
4.5.3 Above 200Kg/Hour Market Size by Manufacturers
4.6 Global Pharmaceutical Dry Granulator Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharmaceutical Dry Granulator Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Dry Granulator Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharmaceutical Dry Granulator Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharmaceutical Dry Granulator Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharmaceutical Dry Granulator Sales and Revenue by Type (2020-2031)
7.4 North America Pharmaceutical Dry Granulator Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharmaceutical Dry Granulator Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharmaceutical Dry Granulator Sales and Revenue by Type (2020-2031)
8.4 Europe Pharmaceutical Dry Granulator Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharmaceutical Dry Granulator Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharmaceutical Dry Granulator Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharmaceutical Dry Granulator Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharmaceutical Dry Granulator Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharmaceutical Dry Granulator Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharmaceutical Dry Granulator Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharmaceutical Dry Granulator Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharmaceutical Dry Granulator Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharmaceutical Dry Granulator Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharmaceutical Dry Granulator Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Fitzpatrick
12.1.1 Fitzpatrick Corporation Information
12.1.2 Fitzpatrick Business Overview
12.1.3 Fitzpatrick Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.1.4 Fitzpatrick Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Fitzpatrick Pharmaceutical Dry Granulator Sales by Product in 2024
12.1.6 Fitzpatrick Pharmaceutical Dry Granulator Sales by Application in 2024
12.1.7 Fitzpatrick Pharmaceutical Dry Granulator Sales by Geographic Area in 2024
12.1.8 Fitzpatrick Pharmaceutical Dry Granulator SWOT Analysis
12.1.9 Fitzpatrick Recent Developments
12.2 Hosokawa
12.2.1 Hosokawa Corporation Information
12.2.2 Hosokawa Business Overview
12.2.3 Hosokawa Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.2.4 Hosokawa Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Hosokawa Pharmaceutical Dry Granulator Sales by Product in 2024
12.2.6 Hosokawa Pharmaceutical Dry Granulator Sales by Application in 2024
12.2.7 Hosokawa Pharmaceutical Dry Granulator Sales by Geographic Area in 2024
12.2.8 Hosokawa Pharmaceutical Dry Granulator SWOT Analysis
12.2.9 Hosokawa Recent Developments
12.3 Alexanderwerk
12.3.1 Alexanderwerk Corporation Information
12.3.2 Alexanderwerk Business Overview
12.3.3 Alexanderwerk Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.3.4 Alexanderwerk Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Alexanderwerk Pharmaceutical Dry Granulator Sales by Product in 2024
12.3.6 Alexanderwerk Pharmaceutical Dry Granulator Sales by Application in 2024
12.3.7 Alexanderwerk Pharmaceutical Dry Granulator Sales by Geographic Area in 2024
12.3.8 Alexanderwerk Pharmaceutical Dry Granulator SWOT Analysis
12.3.9 Alexanderwerk Recent Developments
12.4 Freund Corporation
12.4.1 Freund Corporation Corporation Information
12.4.2 Freund Corporation Business Overview
12.4.3 Freund Corporation Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.4.4 Freund Corporation Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Freund Corporation Pharmaceutical Dry Granulator Sales by Product in 2024
12.4.6 Freund Corporation Pharmaceutical Dry Granulator Sales by Application in 2024
12.4.7 Freund Corporation Pharmaceutical Dry Granulator Sales by Geographic Area in 2024
12.4.8 Freund Corporation Pharmaceutical Dry Granulator SWOT Analysis
12.4.9 Freund Corporation Recent Developments
12.5 Beijing LongliTech
12.5.1 Beijing LongliTech Corporation Information
12.5.2 Beijing LongliTech Business Overview
12.5.3 Beijing LongliTech Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.5.4 Beijing LongliTech Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Beijing LongliTech Pharmaceutical Dry Granulator Sales by Product in 2024
12.5.6 Beijing LongliTech Pharmaceutical Dry Granulator Sales by Application in 2024
12.5.7 Beijing LongliTech Pharmaceutical Dry Granulator Sales by Geographic Area in 2024
12.5.8 Beijing LongliTech Pharmaceutical Dry Granulator SWOT Analysis
12.5.9 Beijing LongliTech Recent Developments
12.6 GERTEIS
12.6.1 GERTEIS Corporation Information
12.6.2 GERTEIS Business Overview
12.6.3 GERTEIS Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.6.4 GERTEIS Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 GERTEIS Recent Developments
12.7 L.B. Bohle
12.7.1 L.B. Bohle Corporation Information
12.7.2 L.B. Bohle Business Overview
12.7.3 L.B. Bohle Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.7.4 L.B. Bohle Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 L.B. Bohle Recent Developments
12.8 Yenchen Machinery
12.8.1 Yenchen Machinery Corporation Information
12.8.2 Yenchen Machinery Business Overview
12.8.3 Yenchen Machinery Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.8.4 Yenchen Machinery Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Yenchen Machinery Recent Developments
12.9 WelchDry
12.9.1 WelchDry Corporation Information
12.9.2 WelchDry Business Overview
12.9.3 WelchDry Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.9.4 WelchDry Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 WelchDry Recent Developments
12.10 Cadmach
12.10.1 Cadmach Corporation Information
12.10.2 Cadmach Business Overview
12.10.3 Cadmach Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.10.4 Cadmach Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Cadmach Recent Developments
12.11 Canaan Technology
12.11.1 Canaan Technology Corporation Information
12.11.2 Canaan Technology Business Overview
12.11.3 Canaan Technology Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.11.4 Canaan Technology Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Canaan Technology Recent Developments
12.12 Bepex
12.12.1 Bepex Corporation Information
12.12.2 Bepex Business Overview
12.12.3 Bepex Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.12.4 Bepex Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Bepex Recent Developments
12.13 Prism Pharma Machinery
12.13.1 Prism Pharma Machinery Corporation Information
12.13.2 Prism Pharma Machinery Business Overview
12.13.3 Prism Pharma Machinery Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.13.4 Prism Pharma Machinery Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Prism Pharma Machinery Recent Developments
12.14 KEYUAN
12.14.1 KEYUAN Corporation Information
12.14.2 KEYUAN Business Overview
12.14.3 KEYUAN Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.14.4 KEYUAN Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 KEYUAN Recent Developments
12.15 KaiChuang Machinery
12.15.1 KaiChuang Machinery Corporation Information
12.15.2 KaiChuang Machinery Business Overview
12.15.3 KaiChuang Machinery Pharmaceutical Dry Granulator Product Models, Descriptions and Specifications
12.15.4 KaiChuang Machinery Pharmaceutical Dry Granulator Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 KaiChuang Machinery Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharmaceutical Dry Granulator Industry Chain
13.2 Pharmaceutical Dry Granulator Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharmaceutical Dry Granulator Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharmaceutical Dry Granulator Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharmaceutical Dry Granulator Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharmaceutical Dry Granulator Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Dry Granulator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Dry Granulator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Dry Granulator Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Dry Granulator Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Dry Granulator Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Pharmaceutical Dry Granulator Sales by Region (2020-2025) & (K Units)
Table 8. Global Pharmaceutical Dry Granulator Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Dry Granulator Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 11. Global Pharmaceutical Dry Granulator Production by Region (2020-2025) & (K Units)
Table 12. Global Pharmaceutical Dry Granulator Production by Region (2026-2031) & (K Units)
Table 13. Global Pharmaceutical Dry Granulator Sales by Manufacturers (2020-2025) & (K Units)
Table 14. Global Pharmaceutical Dry Granulator Sales Share by Manufacturers (2020-2025)
Table 15. Global Pharmaceutical Dry Granulator Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical Dry Granulator Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Pharmaceutical Dry Granulator by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Dry Granulator as of 2024)
Table 19. Global Pharmaceutical Dry Granulator Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Pharmaceutical Dry Granulator Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Pharmaceutical Dry Granulator Manufacturing Base and Headquarters
Table 22. Global Pharmaceutical Dry Granulator Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Pharmaceutical Dry Granulator Sales by Type (2020-2025) & (K Units)
Table 26. Global Pharmaceutical Dry Granulator Sales by Type (2026-2031) & (K Units)
Table 27. Global Pharmaceutical Dry Granulator Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Pharmaceutical Dry Granulator Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Pharmaceutical Dry Granulator ASP by Type (2020-2031) & (US$/Unit)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Pharmaceutical Dry Granulator Sales by Application (2020-2025) & (K Units)
Table 32. Global Pharmaceutical Dry Granulator Sales by Application (2026-2031) & (K Units)
Table 33. Pharmaceutical Dry Granulator High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Pharmaceutical Dry Granulator Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Pharmaceutical Dry Granulator Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Pharmaceutical Dry Granulator ASP by Application (2020-2031) & (US$/Unit)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Pharmaceutical Dry Granulator Growth Accelerators and Market Barriers
Table 40. North America Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Pharmaceutical Dry Granulator Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Pharmaceutical Dry Granulator Growth Accelerators and Market Barriers
Table 43. Europe Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Pharmaceutical Dry Granulator Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Dry Granulator Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Pharmaceutical Dry Granulator Growth Accelerators and Market Barriers
Table 48. Southeast Asia Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Pharmaceutical Dry Granulator Investment Opportunities and Key Challenges
Table 50. Central and South America Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Pharmaceutical Dry Granulator Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Pharmaceutical Dry Granulator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Fitzpatrick Corporation Information
Table 54. Fitzpatrick Description and Major Businesses
Table 55. Fitzpatrick Product Models, Descriptions and Specifications
Table 56. Fitzpatrick Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 57. Fitzpatrick Sales Value Proportion by Product in 2024
Table 58. Fitzpatrick Sales Value Proportion by Application in 2024
Table 59. Fitzpatrick Sales Value Proportion by Geographic Area in 2024
Table 60. Fitzpatrick Pharmaceutical Dry Granulator SWOT Analysis
Table 61. Fitzpatrick Recent Developments
Table 62. Hosokawa Corporation Information
Table 63. Hosokawa Description and Major Businesses
Table 64. Hosokawa Product Models, Descriptions and Specifications
Table 65. Hosokawa Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Hosokawa Sales Value Proportion by Product in 2024
Table 67. Hosokawa Sales Value Proportion by Application in 2024
Table 68. Hosokawa Sales Value Proportion by Geographic Area in 2024
Table 69. Hosokawa Pharmaceutical Dry Granulator SWOT Analysis
Table 70. Hosokawa Recent Developments
Table 71. Alexanderwerk Corporation Information
Table 72. Alexanderwerk Description and Major Businesses
Table 73. Alexanderwerk Product Models, Descriptions and Specifications
Table 74. Alexanderwerk Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Alexanderwerk Sales Value Proportion by Product in 2024
Table 76. Alexanderwerk Sales Value Proportion by Application in 2024
Table 77. Alexanderwerk Sales Value Proportion by Geographic Area in 2024
Table 78. Alexanderwerk Pharmaceutical Dry Granulator SWOT Analysis
Table 79. Alexanderwerk Recent Developments
Table 80. Freund Corporation Corporation Information
Table 81. Freund Corporation Description and Major Businesses
Table 82. Freund Corporation Product Models, Descriptions and Specifications
Table 83. Freund Corporation Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Freund Corporation Sales Value Proportion by Product in 2024
Table 85. Freund Corporation Sales Value Proportion by Application in 2024
Table 86. Freund Corporation Sales Value Proportion by Geographic Area in 2024
Table 87. Freund Corporation Pharmaceutical Dry Granulator SWOT Analysis
Table 88. Freund Corporation Recent Developments
Table 89. Beijing LongliTech Corporation Information
Table 90. Beijing LongliTech Description and Major Businesses
Table 91. Beijing LongliTech Product Models, Descriptions and Specifications
Table 92. Beijing LongliTech Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Beijing LongliTech Sales Value Proportion by Product in 2024
Table 94. Beijing LongliTech Sales Value Proportion by Application in 2024
Table 95. Beijing LongliTech Sales Value Proportion by Geographic Area in 2024
Table 96. Beijing LongliTech Pharmaceutical Dry Granulator SWOT Analysis
Table 97. Beijing LongliTech Recent Developments
Table 98. GERTEIS Corporation Information
Table 99. GERTEIS Description and Major Businesses
Table 100. GERTEIS Product Models, Descriptions and Specifications
Table 101. GERTEIS Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. GERTEIS Recent Developments
Table 103. L.B. Bohle Corporation Information
Table 104. L.B. Bohle Description and Major Businesses
Table 105. L.B. Bohle Product Models, Descriptions and Specifications
Table 106. L.B. Bohle Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. L.B. Bohle Recent Developments
Table 108. Yenchen Machinery Corporation Information
Table 109. Yenchen Machinery Description and Major Businesses
Table 110. Yenchen Machinery Product Models, Descriptions and Specifications
Table 111. Yenchen Machinery Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Yenchen Machinery Recent Developments
Table 113. WelchDry Corporation Information
Table 114. WelchDry Description and Major Businesses
Table 115. WelchDry Product Models, Descriptions and Specifications
Table 116. WelchDry Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. WelchDry Recent Developments
Table 118. Cadmach Corporation Information
Table 119. Cadmach Description and Major Businesses
Table 120. Cadmach Product Models, Descriptions and Specifications
Table 121. Cadmach Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Cadmach Recent Developments
Table 123. Canaan Technology Corporation Information
Table 124. Canaan Technology Description and Major Businesses
Table 125. Canaan Technology Product Models, Descriptions and Specifications
Table 126. Canaan Technology Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Canaan Technology Recent Developments
Table 128. Bepex Corporation Information
Table 129. Bepex Description and Major Businesses
Table 130. Bepex Product Models, Descriptions and Specifications
Table 131. Bepex Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. Bepex Recent Developments
Table 133. Prism Pharma Machinery Corporation Information
Table 134. Prism Pharma Machinery Description and Major Businesses
Table 135. Prism Pharma Machinery Product Models, Descriptions and Specifications
Table 136. Prism Pharma Machinery Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Prism Pharma Machinery Recent Developments
Table 138. KEYUAN Corporation Information
Table 139. KEYUAN Description and Major Businesses
Table 140. KEYUAN Product Models, Descriptions and Specifications
Table 141. KEYUAN Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. KEYUAN Recent Developments
Table 143. KaiChuang Machinery Corporation Information
Table 144. KaiChuang Machinery Description and Major Businesses
Table 145. KaiChuang Machinery Product Models, Descriptions and Specifications
Table 146. KaiChuang Machinery Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 147. KaiChuang Machinery Recent Developments
Table 148. Key Raw Materials Distribution
Table 149. Raw Materials Key Suppliers
Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 151. Milestones in Production Technology Evolution
Table 152. Distributors List
Table 153. Market Trends and Market Evolution
Table 154. Market Drivers and Opportunities
Table 155. Market Challenges, Risks, and Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Dry Granulator Product Picture
Figure 2. Global Pharmaceutical Dry Granulator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Below 30Kg/Hour Product Picture
Figure 4. 30-200Kg/Hour Product Picture
Figure 5. Above 200Kg/Hour Product Picture
Figure 6. Global Pharmaceutical Dry Granulator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Mid-size & Small Pharma Companies
Figure 8. Large Pharma Companies
Figure 9. Pharmaceutical Dry Granulator Report Years Considered
Figure 10. Global Pharmaceutical Dry Granulator Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pharmaceutical Dry Granulator Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pharmaceutical Dry Granulator Revenue Market Share by Region (2020-2031)
Figure 14. Global Pharmaceutical Dry Granulator Sales (2020-2031) & (K Units)
Figure 15. Global Pharmaceutical Dry Granulator Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Pharmaceutical Dry Granulator Sales Market Share by Region (2020-2031)
Figure 17. Global Pharmaceutical Dry Granulator Capacity, Production and Utilization (2020-2031) & (K Units)
Figure 18. Global Pharmaceutical Dry Granulator Production Trend by Region (2020-2031) (K Units)
Figure 19. Global Pharmaceutical Dry Granulator Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Pharmaceutical Dry Granulator Production Growth Rate in North America (2020-2031) & (K Units)
Figure 22. Pharmaceutical Dry Granulator Production Growth Rate in Europe (2020-2031) & (K Units)
Figure 23. Pharmaceutical Dry Granulator Production Growth Rate in China (2020-2031) & (K Units)
Figure 24. Pharmaceutical Dry Granulator Production Growth Rate in Japan (2020-2031) & (K Units)
Figure 25. Top 5 and Top 10 Manufacturers Pharmaceutical Dry Granulator Sales Volume Market Share in 2024
Figure 26. Global Pharmaceutical Dry Granulator Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Below 30Kg/Hour Revenue Market Share by Manufacturer in 2024
Figure 29. 30-200Kg/Hour Revenue Market Share by Manufacturer in 2024
Figure 30. Above 200Kg/Hour Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Pharmaceutical Dry Granulator Sales Market Share by Type (2020-2031)
Figure 34. Global Pharmaceutical Dry Granulator Revenue Market Share by Type (2020-2031)
Figure 35. Global Pharmaceutical Dry Granulator Sales Market Share by Application (2020-2031)
Figure 36. Global Pharmaceutical Dry Granulator Revenue Market Share by Application (2020-2031)
Figure 37. North America Pharmaceutical Dry Granulator Sales YoY (2020-2031) & (K Units)
Figure 38. North America Pharmaceutical Dry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Pharmaceutical Dry Granulator Sales Revenue (US$ Million) in 2024
Figure 40. North America Pharmaceutical Dry Granulator Sales Volume (K Units) by Type (2020- 2031)
Figure 41. North America Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Pharmaceutical Dry Granulator Sales Volume (K Units) by Application (2020-2031)
Figure 43. North America Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Pharmaceutical Dry Granulator Sales YoY (2020-2031) & (K Units)
Figure 48. Europe Pharmaceutical Dry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Pharmaceutical Dry Granulator Sales Revenue (US$ Million) in 2024
Figure 50. Europe Pharmaceutical Dry Granulator Sales Volume (K Units) by Type (2020-2031)
Figure 51. Europe Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Pharmaceutical Dry Granulator Sales Volume (K Units) by Application (2020-2031)
Figure 53. Europe Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 55. France Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Pharmaceutical Dry Granulator Sales YoY (2020-2031) & (K Units)
Figure 60. Asia-Pacific Pharmaceutical Dry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Pharmaceutical Dry Granulator Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Pharmaceutical Dry Granulator Sales Volume (K Units) by Type (2020- 2031)
Figure 63. Asia-Pacific Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Pharmaceutical Dry Granulator Sales Volume (K Units) by Application (2020-2031)
Figure 65. Asia-Pacific Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 70. India Pharmaceutical Dry Granulator Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Pharmaceutical Dry Granulator Sales YoY (2020-2031) & (K Units)
Figure 72. Central and South America Pharmaceutical Dry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Pharmaceutical Dry Granulator Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Pharmaceutical Dry Granulator Sales Volume (K Units) by Type (2021-2031)
Figure 75. Central and South America Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Pharmaceutical Dry Granulator Sales Volume (K Units) by Application (2020-2031)
Figure 77. Central and South America Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Pharmaceutical Dry Granulator Sales YoY (2020-2031) & (K Units)
Figure 81. Middle East and Africa Pharmaceutical Dry Granulator Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Pharmaceutical Dry Granulator Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Pharmaceutical Dry Granulator Sales Volume (K Units) by Type (2021-2031)
Figure 84. South America Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Pharmaceutical Dry Granulator Sales Volume (K Units) by Application (2020-2031)
Figure 86. Middle East and Africa Pharmaceutical Dry Granulator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Pharmaceutical Dry Granulator Revenue (2020-2025) & (US$ Million)
Figure 91. Pharmaceutical Dry Granulator Industry Chain Mapping
Figure 92. Regional Pharmaceutical Dry Granulator Manufacturing Base Distribution (%)
Figure 93. Pharmaceutical Dry Granulator Production Process
Figure 94. Regional Pharmaceutical Dry Granulator Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Dry Granulator market?
The top companies in the global Pharmaceutical Dry Granulator market are Fitzpatrick、Hosokawa、Alexanderwerk.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Pharmaceutical Dry Granulator market size from 2025 to 2031?
What was the global market size of Pharmaceutical Dry Granulator in 2031?
What was the global market size of Pharmaceutical Dry Granulator in 2025?
Related Reports
Global Pharmaceutical Dry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 91
USD 4250.00
(Single User License)
Pharmaceutical Dry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 167 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 111
USD 3950.00
(Single User License)
Global Pharmaceutical Dry Granulator Market Research Report 2026
The global Pharmaceutical Dry Granulator market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 167 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 142
USD 2900.00
(Single User License)
Global Pharmaceutical Dry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
Pharmaceutical Dry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-02-09
Pages: 119
USD 3950.00
(Single User License)
Global Pharmaceutical Dry Granulator Market Research Report 2025
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-02-09
Pages: 105
USD 2900.00
(Single User License)
Pharmaceutical Dry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 148
USD 3950.00
(Single User License)
Global Pharmaceutical Dry Granulator Market Insights, Forecast to 2030
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-04-12
Pages: 115
USD 4900.00
(Single User License)
Global Pharmaceutical Dry Granulator Market Research Report 2024
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 110
USD 2900.00
(Single User License)
Pharmaceutical Dry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-01-08
Pages: 140
USD 3950.00
(Single User License)
Global Pharmaceutical Dry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 91
USD 4250.00 (Single User License)Pharmaceutical Dry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 167 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 111
USD 3950.00 (Single User License)Global Pharmaceutical Dry Granulator Market Research Report 2026
The global Pharmaceutical Dry Granulator market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 167 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 142
USD 2900.00 (Single User License)Global Pharmaceutical Dry Granulator Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
USD 4250.00 (Single User License)Pharmaceutical Dry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 119
USD 3950.00 (Single User License)Global Pharmaceutical Dry Granulator Market Research Report 2025
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-02-09
Pages: 105
USD 2900.00 (Single User License)Pharmaceutical Dry Granulator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 148
USD 3950.00 (Single User License)Global Pharmaceutical Dry Granulator Market Insights, Forecast to 2030
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-04-12
Pages: 115
USD 4900.00 (Single User License)Global Pharmaceutical Dry Granulator Market Research Report 2024
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 110
USD 2900.00 (Single User License)Pharmaceutical Dry Granulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-01-08
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now